| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |